Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
160.89B
Market cap160.89B
Price-Earnings ratio
10.83
Price-Earnings ratio10.83
Dividend yield
3.26%
Dividend yield3.26%
Average volume
34.60M
Average volume34.60M
High today
$37.50
High today$37.50
Low today
$35.85
Low today$35.85
Open price
$36.36
Open price$36.36
Volume
34.25M
Volume34.25M
52 Week high
$91.90
52 Week high$91.90
52 Week low
$35.85
52 Week low$35.85

NVO News

Bloomberg 1h
Danish Economy to Outpace Nordics Despite Novo Woes, Danske Says

Denmark’s economy is poised to expand at the fastest pace in the Nordic region this year, even as pharmaceutical giant Novo Nordisk A/S grapples with slowing sa...

Danish Economy to Outpace Nordics Despite Novo Woes, Danske Says
TipRanks 9h
Option traders moderately bearish in Novo Nordisk with shares down 2.87%

Option traders moderately bearish in Novo Nordisk (NVO), with shares down $1.08 near $36.67. Options volume roughly in line with average with 140k contracts tra...

The Motley Fool 10h
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?

Eli Lilly's (LLY 1.09%) big problem is its success in the GLP-1 drug space. Its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs grew sales by 99% a...

Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?

Analyst ratings

59%

of 34 ratings
Buy
35.3%
Hold
58.8%
Sell
5.9%

More NVO News

The Motley Fool 16h
Scholar Rock Q4 2025 Earnings Transcript

Image source: The Motley Fool. Tuesday, March 3, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer — David Hallal President and Head of Research &...

Scholar Rock Q4 2025 Earnings Transcript
Simply Wall St 20h
Assessing Novo Nordisk Valuation After Recent Share Price Weakness

Advertisement Event-driven snapshot of Novo Nordisk (NYSE:NVO) Novo Nordisk (NYSE:NVO) has drawn investor attention after its recent share performance, with t...

Assessing Novo Nordisk Valuation After Recent Share Price Weakness
TipRanks 21h
Novo Nordisk upgraded to Equal Weight from Underweight at Morgan Stanley

Morgan Stanley upgraded Novo Nordisk (NVO) to Equal Weight from Underweight with a price target of $40, down from $42. Post the selloff on the REDEFINE-4 data,...

TipRanks 2d
Novo Nordisk Employees Elect New Board Representatives Ahead of March AGM

An update from Novo Nordisk ( (NVO) ) is now available. On 2 March 2026, Novo Nordisk employees completed the election of new employee representatives to the c...

The Motley Fool 2d
Why I'm Not Worried About Novo Nordisk Stock

Novo Nordisk (NVO 0.37%) stock has been a trainwreck of late. In just the past 12 months, the Danish healthcare stock has lost around 60% of its value. Things h...

Why I'm Not Worried About Novo Nordisk Stock
TipRanks 2d
Eli Lilly Stock Falls as Rival Novo Nordisk Expands Weight-Loss Pill Manufacturing

Eli Lilly’s (LLY) stock is down 2% on reports that rival Novo Nordisk (NVO) is spending more than $500 million to expand the manufacturing of its Wegovy weight-...

TipRanks 2d
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs analyst James Quigley downgraded Novo Nordisk (NVO) to Neutral from Buy with a price target of $41, down from $63. The firm cut estimates for Cagr...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.